Université de Lyon, Villeurbanne F-69622, France.
Bioorg Med Chem. 2009 Oct 15;17(20):7290-300. doi: 10.1016/j.bmc.2009.08.048. Epub 2009 Sep 3.
Presence of basic calcium phosphate in knee joints of osteoarthritis patients could be prevented by inhibiting tissue non-specific alkaline phosphatase (TNAP) activity. Levamisole or the L stereoisomer of tetramisole (a known TNAP inhibitor) has been used as a treatment for curing rheumatoid arthritis but its therapeutical use is limited due to side effects. We report the synthesis and the TNAP inhibition property of benzo[b]thiophene derivatives, among which benzothiopheno-tetramisole and benzothiopheno-2,3-dehydrotetramisole, which could be involved in a drug therapy for osteoarthritis. Two water soluble racemic benzothiopheno-tetramisole and -2,3-dehydrotetramisole with apparent inhibition constants K(i)=85+/-6 microM and 135+/-3 microM (n=3) comparable to that of enantiomeric levamisole 93+/-4 microM were found. Several novel derivatives showed more pronounced inhibition properties towards intestinal alkaline phosphatase than TNAP.
在骨关节炎患者的膝关节中存在的基本磷酸钙可以通过抑制组织非特异性碱性磷酸酶(TNAP)的活性来预防。左旋咪唑或四咪唑的 L 对映异构体(一种已知的 TNAP 抑制剂)已被用作治疗类风湿性关节炎的药物,但由于副作用,其治疗用途受到限制。我们报告了苯并[b]噻吩衍生物的合成和 TNAP 抑制特性,其中苯并噻吩并四咪唑和苯并噻吩并 2,3-去氢四咪唑可能参与骨关节炎的药物治疗。两种水溶性外消旋苯并噻吩并四咪唑和苯并噻吩并 2,3-去氢四咪唑的表观抑制常数 K(i)=85+/-6 microM 和 135+/-3 microM(n=3)与对映异构体左旋咪唑 93+/-4 microM 相当。一些新的衍生物对肠道碱性磷酸酶的抑制作用比 TNAP 更明显。